Gerlind Holberg

1.2k total citations · 1 hit paper
9 papers, 822 citations indexed

About

Gerlind Holberg is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Gerlind Holberg has authored 9 papers receiving a total of 822 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Internal Medicine, 8 papers in Cardiology and Cardiovascular Medicine and 3 papers in Surgery. Recurrent topics in Gerlind Holberg's work include Venous Thromboembolism Diagnosis and Management (9 papers), Atrial Fibrillation Management and Outcomes (7 papers) and Cardiac, Anesthesia and Surgical Outcomes (2 papers). Gerlind Holberg is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (9 papers), Atrial Fibrillation Management and Outcomes (7 papers) and Cardiac, Anesthesia and Surgical Outcomes (2 papers). Gerlind Holberg collaborates with scholars based in Canada, Germany and Italy. Gerlind Holberg's co-authors include Scott D. Berkowitz, Martin Homering, Richard J. Friedman, Timothy Brighton, Martin H. Prins, Henri Bounameaux, Anthonie W.A. Lensing, Ajay K. Kakkar, Lloyd Haskell and Bonno van Bellen and has published in prestigious journals such as New England Journal of Medicine, Blood and Journal of the American College of Cardiology.

In The Last Decade

Gerlind Holberg

9 papers receiving 790 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

2017 492 citations Jeffrey I. Weitz, Anthonie W.A. Lensing et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Gerlind Holberg

Since Specialization

Citations

This map shows the geographic impact of Gerlind Holberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerlind Holberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerlind Holberg more than expected).

Fields of papers citing papers by Gerlind Holberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerlind Holberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerlind Holberg. The network helps show where Gerlind Holberg may publish in the future.

Co-authorship network of co-authors of Gerlind Holberg

This figure shows the co-authorship network connecting the top 25 collaborators of Gerlind Holberg. A scholar is included among the top collaborators of Gerlind Holberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerlind Holberg. Gerlind Holberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Title	Journal	Authors	Indexed citations
1	Bleeding Outcomes in Patients Treated With Asundexian in Phase II Trials	Journal of the American College of Cardiology	John W. Eikelboom, Hardi Mundl et al.	4
2	Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism breakdown →	New England Journal of Medicine	Jeffrey I. Weitz, Anthonie W.A. Lensing et al.	492
3	The effects of timing of prophylaxis, type of anesthesia, and use of mechanical methods on outcome in major orthopedic surgery - subgroup analyses from 17,701 patients in the XAMOS study	Vascular Health and Risk Management	Sylvia Haas, Gerlind Holberg et al.	5
4	Two doses of rivaroxaban versus aspirin for prevention of recurrent venous thromboembolism	Thrombosis and Haemostasis	Rupert Bauersachs, Jan Beyer‐Westendorf et al.	35
5	Rivaroxaban for Thromboprophylaxis After Fracture-Related Orthopedic Surgery in Routine Clinical Practice	Clinical and Applied Thrombosis/Hemostasis	Michael R. Lassen, Sylvia Haas et al.	13
6	Rivaroxaban compared with standard thromboprophylaxis after major orthopaedic surgery: co‐medication interactions	British Journal of Clinical Pharmacology	Reinhold Kreutz, Sylvia Haas et al.	13
7	Allogeneic Blood Transfusions and Postoperative Infections After Total Hip or Knee Arthroplasty	Journal of Bone and Joint Surgery	Richard J. Friedman, Martin Homering et al.	186
8	A non-interventional comparison of rivaroxaban with standard of care for thromboprophylaxis after major orthopaedic surgery in 17,701 patients with propensity score adjustment	Thrombosis and Haemostasis	Sylvia Haas, Reinhold Kreutz et al.	71
9	Rivaroxaban for Thromboprophylaxis After Total Hip or Knee Replacement Surgery: Comparison of Outcomes of the XAMOS and RECORD Studies	Blood	Alexander G.G. Turpie, André Schmidt et al.	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact